Overall, the pooled results showed a higher serum level of galectin-3 in patients with COPD compared to healthy controls (SMD ═ 0.60, 95% CI 0.40–0.80; P < 0.001; I2 ═ 68%; Figure 2). Here, LGALS3 is linked to chronic obstructive pulmonary disease.